Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34152993)
Watch
English
Tamoxifen ("Nolvadex"): a review.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Tamoxifen ("Nolvadex"): a review
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
main subject
tamoxifen
1 reference
based on heuristic
inferred from title
author
Anthony Howell
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
Mark Clemons
series ordinal
1
object named as
M Clemons
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
author name string
S Danson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
publication date
1 August 2002
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
published in
Cancer Treatment Reviews
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
volume
28
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
issue
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
page(s)
165-180
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
cites work
A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toxicologic studies on clomiphene.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new derivative of triphenylethylene: effect on implantation and mode of action in rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New synthetic agent for the induction of ovulation: preliminary trials in women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antioestrogens in the management of hormone-dependent cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen (Nolvadex) versus adrenalectomy in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: a sequential trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of metastatic breast cancer in estrogen receptor positive patients. A randomized trial comparing tamoxifen alone versus tamoxifen plus CMF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Christie hospital adjuvant tamoxifen trial--status at 10 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long term effects of tamoxifen on blood lipid values in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Five years of tamoxifen--or more?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and contralateral breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is tamoxifen effective in prevention of breast cancer?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen resistance in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endocrine-responsive breast cancer and strategies for combating resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alternative mechanisms of action of anti-oestrogens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gynecologic effects of tamoxifen and the association with endometrial carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamoxifen and secondary tumours. An update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality from breast cancer in UK has decreased suddenly
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900036-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0305-7372(02)00036-1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
PubMed publication ID
12363457
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12363457
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12363457%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit